Correlation Between Vascular Biogenics and Denali Therapeutics

Can any of the company-specific risk be diversified away by investing in both Vascular Biogenics and Denali Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vascular Biogenics and Denali Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vascular Biogenics and Denali Therapeutics, you can compare the effects of market volatilities on Vascular Biogenics and Denali Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vascular Biogenics with a short position of Denali Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vascular Biogenics and Denali Therapeutics.

Diversification Opportunities for Vascular Biogenics and Denali Therapeutics

-0.4

Correlation Coefficient

Vascular Biogenics  Denali Therapeutics

Very good diversification

The 3 months correlation between Vascular and Denali is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Vascular Biogenics and Denali Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Denali Therapeutics and Vascular Biogenics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vascular Biogenics are associated (or correlated) with Denali Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Denali Therapeutics has no effect on the direction of Vascular Biogenics i.e., Vascular Biogenics and Denali Therapeutics go up and down completely randomly.

Pair Corralation between Vascular Biogenics and Denali Therapeutics

If you would invest  16.00  in Vascular Biogenics on January 18, 2024 and sell it today you would earn a total of  0.00  from holding Vascular Biogenics or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	4.55%
Values	Daily Returns

Vascular Biogenics  vs.  Denali Therapeutics

Vascular Biogenics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vascular Biogenics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Vascular Biogenics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Denali Therapeutics

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Denali Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak essential indicators, Denali Therapeutics demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Vascular Biogenics and Denali Therapeutics

The main advantage of trading using opposite Vascular Biogenics and Denali Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vascular Biogenics position performs unexpectedly, Denali Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denali Therapeutics will offset losses from the drop in Denali Therapeutics' long position.

The idea behind Vascular Biogenics and Denali Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.